share_log
Reuters ·  Mar 21 11:28
Shanghai Junshi Biosciences - Approval of Supplemental New Drug Application for Toripalimab in Combination With Bevacizumab by Nmpa
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 380

Recommended

Write a comment